Results 161 to 170 of about 3,122,352 (307)
Enrichment of HLA-DR<sup>+</sup> neutrophils in osteoarthritic infrapatellar fat pad. [PDF]
Bevc K +12 more
europepmc +1 more source
Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential
Schematic overview of bone remodeling dysregulation in osteoporosis and the multi‐target protective role of herbal therapeutics. ABSTRACT Osteoporosis is a chronic bone disease marked by reduced density and increased fracture risk. Current treatments face limitations in safety, efficacy, and long‐term adherence, prompting interest in alternative ...
Elnaz Vafadar Moradi +5 more
wiley +1 more source
HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know. [PDF]
Yap CF, Viatte S.
europepmc +1 more source
A proposed mechanistic framework of systemic lupus erythematosus (SLE) and autoimmune thyroid disease (AITD) pathogenesis. In Stage 1, genetically susceptible individuals harbor risk variants within major histocompatibility complex (HLA) and non‐HLA loci that impair central and peripheral immune tolerance mechanisms within the thymic and peripheral ...
Elisa Elisa +3 more
wiley +1 more source
Immunological impact of age and comorbidities: findings from the REALISM and SENIOR-HLA-DR cohorts. [PDF]
Vieilledent L +11 more
europepmc +1 more source
ABSTRACT Background The causes of late onset Alzheimer disease (LOAD) are not known but several recent lines of evidence implicate the adaptive immune system. Objective To characterize the adaptive immune system among Midwestern Amish participating in longitudinal studies of aging.
Lauren A. Cruz +18 more
wiley +1 more source
Mendelian randomization analysis links HLA-DR+ CD14- CD16+ monocytes to CCL19-driven ankylosing spondylitis risk. [PDF]
Bei L, Liao J, Tan C, Li X, Yang Z.
europepmc +1 more source
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija +6 more
wiley +1 more source

